We are increasingly able to turn to non-surgical therapies for structural and valvular heart disease. Host Dr. Lee Freedman discusses investigational, catheter-based treatment with Dr. Howard Herrmann, professor of medicine, and director of interventional cardiology and the Cardiac Catheterization Laboratories within the University of Pennsylvania Health System. What new devices are making these advances possible? What are the procedural risks?
Investigational Approaches to Structural and Valvular Heart Disease

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
We are increasingly able to turn to non-surgical therapies for structural and valvular heart disease. Host Dr. Lee Freedman discusses investigational, catheter-based treatment with Dr. Howard Herrmann, professor of medicine, and director of interventional cardiology and the Cardiac Catheterization Laboratories within the University of Pennsylvania Health System. What new devices are making these advances possible? What are the procedural risks?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?